The company has entered into a definitive agreement to sell a Rare Pediatric Disease Priority Review Voucher (PRV) for $210 ...

Investor risk aversion was identified as the leading constraint on biotech investment, cited by 64% of respondents. In Europe ...

In a recent presentation at the Medicaid Drug Rebate Program Summit, Lorilyn Rosales-Menzel, associate general counsel for US ...

Prader-Willi syndrome is a rare genetic condition that can present from birth. Its occurrence is around 1 in 15,000, and tens ...

This investment hesitation represents more than financial calculations—it threatens the pipeline of future therapies. “The ...

Viatris will acquire all outstanding shares of Pacira's common stock for $36.50 per share, representing an aggregate equity ...

Pharma industry is navigating its biggest drug pricing compliance overhaul since 2006, as CMS’ 2026 Physician Fee Schedule ...

This webinar will explore integrating the Pfenex Expression Technology® platform directly into the antibody screening ...

Partnership aims to improve patient access and adherence through mobile-first engagement platform for life sciences firms ...

Agency plans extensive changes to Clinical Trials Information System to enable faster study assessments and greater ...

Legal cases highlight how diagnostic programs can cross compliance lines when data drives sales rather than patient care ...

Organizations shift from manual compliance to embedded digital systems with continuous oversight, data integration and ...